5 Cheap Pharmaceutical Stocks For 2022

2. Kaleido Biosciences, Inc. (NASDAQ:KLDO)

Number of Hedge Fund Holders: 4     

Real-Time Share Price as of February 15: $1.57

Kaleido Biosciences, Inc. (NASDAQ:KLDO) is a clinical-stage healthcare firm. Major hedge funds hold large stakes in the company. Among the hedge funds being tracked by Insider Monkey, California-based investment firm Palo Alto Investors is a leading shareholder in Kaleido Biosciences, Inc. (NASDAQ:KLDO), with 786,400 shares worth more than $4.2 million.  

Kaleido Biosciences, Inc. (NASDAQ:KLDO) is working on the development of drugs related to the treatment of urea cycle disorder, ulcerative colitis, hepatic encephalopathy, and the COVID-19 disease, among others.